Susquehanna International Group, LLP Immunity Bio, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 379,101 shares of IBRX stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
379,101
Previous 111,388
240.34%
Holding current value
$1.36 Million
Previous $598,000
300.5%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IBRX
# of Institutions
216Shares Held
63.3MCall Options Held
1.43MPut Options Held
4.12M-
Vanguard Group Inc Valley Forge, PA13.8MShares$49.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$41.1 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$28.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$14.1 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$6.18 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.44B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...